@prefix dcterms: . @prefix dgn-np: . @prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_head { this: np:hasAssertion dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_assertion; np:hasProvenance dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_provenance; np:hasPublicationInfo dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_publicationInfo; a np:Nanopublication . dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_assertion a np:Assertion . dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_provenance a np:Provenance . dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_publicationInfo a np:PublicationInfo . } dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_assertion { miriam-gene:2064 a ncit:C16612 . lld:C0001418 a ncit:C7057 . dgn-gda:DGN8dfce5de42eecfcc1ce5b593f4a6cefb sio:SIO_000628 miriam-gene:2064, lld:C0001418; a sio:SIO_001121 . } dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_provenance { dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_assertion dcterms:description "[Among the findings: peptic ulcer disease is a significant predisposing risk factor (odds ratio = 3.9) for pancreatic cancer; as many as 50% of all intraductal papillary mucinous neoplasms are associated with invasive adenocarcinomas; alteration of gene expression via methylation of a gene promotor region constitutes a potentially reversible method of tumor suppressor gene inactivation; > 400 transcriptional alterations of gene expression have been identified for pancreatic cancer; some common molecular markers such as p53 and HER-2/neu may be related to morphologic alterations of in situ neoplasia and to transcriptional alterations of gene expression rather than mutational events; epidermal growth factor (EGF), transforming growth factor beta (TGF-beta), and related molecules may modulate gene transcription via autocrine or paracrine mechanisms; several cytokines, amylin (islet amyloid polypeptide), and other cachexia factors are responsible for paraneoplastic peripheral insulin resistance, ineffective utilization of glucose, and profound cachexia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:9821173; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP1409092.RAzbfF_Qj17snfFC2KKiHLfyYB8QvpHUXoYVCG_x6FU2M130_publicationInfo { this: dcterms:created "2016-05-13T12:52:25+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }